According to Matinas BioPharma's latest financial reports the company's current earnings (TTM) are -$22.95 M. In 2022 the company made an earning of -$21 M an increase over its 2021 earnings that were of -$23.29 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$22.95 M | 9.26% |
2022 | -$21 M | -9.82% |
2021 | -$23.29 M | 3.73% |
2020 | -$22.45 M | 29.21% |
2019 | -$17.38 M | 19.07% |
2018 | -$14.59 M | -7.91% |
2017 | -$15.85 M | 108.5% |
2016 | -$7.6 M | -16.82% |
2015 | -$9.14 M | -10.62% |
2014 | -$10.23 M | 175.27% |
2013 | -$3.72 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 382.87% | ๐บ๐ธ USA |